AUSTIN, Texas, Dec. 5, 2016 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company was awarded the prestigious R&D 100 Award for its ARIES® Systems at the 54th Annual R&D 100 Awards ceremony in November. The R&D 100 Awards, presented by R&D Magazine, is an international competition that honors the 100 best technologies of the year. The award recognizes technologically significant products across a wide range of industries, including telecommunications, optics, high-energy physics, materials science, chemistry, and biotechnology, and provides a mark of excellence recognized by industry, government, and consumers.
“We developed the ARIES® family of systems based on extensive input from customers, and are honored to win this award on their behalf,” said Homi Shamir, President and Chief Executive Officer of Luminex. “ARIES® answers many of the previously unmet needs of our clinical laboratory customers while delivering accurate and timely data to improve patient care. In the year that the systems have been on the market, we have been very encouraged by the response from the laboratory community as well as the various international regulatory bodies that have issued approvals or marketing clearance for our ARIES® systems and assays.”
About the ARIES Systems
ARIES® Systems are sample to answer molecular diagnostic systems designed to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today’s lean laboratory environment. ARIES® uses internal barcode scanning and other advanced features to minimize operator errors. Independent modules support from one to six cassettes, allowing for both STAT and Batch testing of IVD assays and laboratory developed tests (LDTs) with MultiCode® Reagents when using a universal assay protocol. An integrated touchscreen PC eliminates the need for a separate computer, standalone keyboard, and mouse, maximizing valuable bench space.
To learn more or request a demo, visit: www.luminexcorp.com/ARIES
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
|
Contacts |
|
|
Luminex Investor Contact |
Luminex Media Contact |
|
Harriss Currie |
Christine Valle |
|
Sr. Vice President of Finance and CFO |
Sr. Manager, Global Marketing |
|
512.219.8020 |
512.219.8020 |
Photo – http://photos.prnewswire.com/prnh/20161202/445232
Logo – http://photos.prnewswire.com/prnh/20150201/172702LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/luminex-wins-rd-100-award-for-aries-systems-300372418.html
SOURCE Luminex Corporation
http://investor.luminexcorp.com/phoenix.zhtml?c=79403&p=RssLanding&cat=news&id=2227442